PeptidePedia The community reference

Reconstitution calculator (revision 35)

Old revision·13:06, 11 May 2025·StubSorterBot

This is an old revision of this page, as it stood at 13:06, 11 May 2025, saved by StubSorterBot with the summary bot: update parent category chain. It may differ substantially from the current revision, and any error it contains may since have been corrected.
For the underlying procedure and its sources, see Reconstitution of lyophilised peptides. For the syringe scales, see Insulin syringe unit conversion.
Reconstitution calculatorInteractive reference tool
010203040506070809010042 units = 0.42 mLU-100 insulin syringe, 1 mL barrel
A U-100 syringe scale is a volume scale: 42 units is 0.42 mL regardless of what the vial contains.
InputsVial mass (mg), diluent volume (mL), dose (mg or µg), syringe scale
OutputsConcentration, dose volume, syringe units, doses per vial
Method
ConcentrationC = m / V
Dose volumeVd = D / C
Syringe unitsU = Vd × S, S = 100, 50 or 40 per mL
AssumptionNegligible volume displacement by the solid
Scope
What it isA unit converter
What it is notA clinical decision tool
RunsEntirely in the browser
Reference tool infobox · conventions

The reconstitution calculator relates the four quantities involved in dissolving a lyophilised peptide and drawing a dose from it: the mass of solid in the vial, the volume of diluent added, the intended dose, and the reading on the syringe barrel. All four are connected by one division, and almost every error reported in the literature and in community accounts is a confusion between two of them rather than a failure of the arithmetic itself.[1]

The calculation is a routine unit conversion: concentration is mass divided by volume, dose volume is dose divided by concentration, and a syringe unit is one hundredth of a millilitre on the U-100 scale. The tool below performs those operations and shows each intermediate result, because the intermediate is where a mistake becomes visible.

This page is a reference tool and not a clinical decision aid. It converts numbers a reader enters; it does not select a dose, and it has no knowledge of the vial, the label claim, or the person. See Project:Medical disclaimer.

The calculator

[edit]

Enter the label mass of the vial, the volume of diluent, and the intended dose. The tool reports the resulting concentration, the volume that dose occupies, the reading on the selected syringe scale, and how many doses the vial contains.

Worked examples

[edit]

The tool's defaults correspond to the first row below. Each row is a division; none of them requires a calculator, and reproducing one by hand is a useful check that the inputs were entered as intended.

Concentration and dose volume for common vial and diluent combinations
VialDiluentConcentrationDoseDose volumeU-100 units
5 mg2.0 mL2.5 mg/mL0.25 mg0.10 mL10
5 mg2.0 mL2.5 mg/mL0.50 mg0.20 mL20
5 mg1.0 mL5.0 mg/mL0.25 mg0.05 mL5
10 mg2.0 mL5.0 mg/mL2.5 mg0.50 mL50
10 mg1.0 mL10 mg/mL1.0 mg0.10 mL10
15 mg3.0 mL5.0 mg/mL7.5 mg1.50 mL150
2 mg2.0 mL1.0 mg/mL100 µg0.10 mL10

The last row illustrates the most common unit confusion: a dose expressed in micrograms against a concentration expressed in milligrams per millilitre. One thousand micrograms is one milligram, so 100 µg of a 1 mg/mL solution is 0.1 mL — ten units on a U-100 syringe, not one hundred.

Two rows are worth noticing for a different reason. A 150-unit dose does not fit in a 1 mL insulin syringe, and the tool warns when a computed volume exceeds a plausible barrel. A 5-unit dose sits at the very bottom of a U-100 barrel, where the graduation interval is a large fraction of the dose and precision is correspondingly poor; a lower concentration would place the same dose further up the scale.[2]

What the label mass means

[edit]

The calculation above treats the vial's label mass as the mass of peptide present. That is an assumption, and on a certificate of analysis it is frequently not true. A lyophilised solid contains water (typically 3–8% by mass), a counterion (2–12%), and residual salts, all of which occupy the labelled mass unless the label claim is explicitly a net peptide figure.[3]

A vial labelled 10 mg with 5.2% water and 6.4% trifluoroacetate contains approximately

10 × (1 − 0.052 − 0.064) ≈ 8.7\,mg

of peptide-plus-related-substances, before any correction for chromatographic purity. Entering 10 mg into the calculator therefore yields a concentration about 13% higher than the peptide concentration actually achieved.

Volume displacement and dead space

[edit]

Two systematic effects are worth stating because the calculator does not model the first and only optionally models the second.

Displacement. Adding 2 mL of diluent to a vial containing 5 mg of solid produces slightly more than 2 mL of solution, because the dissolved solid occupies volume. For peptide masses of a few milligrams in a millilitre or more of diluent the effect is on the order of a few thousandths of a millilitre and is negligible against the graduation interval of the syringe. It ceases to be negligible when the solid mass approaches the diluent volume, which does not arise in the cases this tool is used for.

Dead space. Volume retained in the syringe hub and needle after the plunger is fully depressed is not delivered. Reported figures range from roughly 0.02 mL for a low-dead-space insulin syringe with a fixed needle to 0.07 mL or more for a detachable-needle arrangement.[4] Against a 0.10 mL dose that is a 20–70% loss if the syringe is not primed, which is why the dead-space field exists: entering a figure shows its effect on the number of doses the vial yields, not on the delivered dose, since a primed syringe delivers its nominal volume.

See also

References

  1. ^ United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations". USP–NF, current revision.
  2. ^ ISO 7886-1, Sterile hypodermic syringes for single use — Part 1: Syringes for manual use. International Organization for Standardization.
  3. ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.
  4. ^ World Health Organization, WHO Guideline on the Use of Safety-Engineered Syringes (2015) — includes dead-space characterisation of syringe types.